Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

被引：0
|
作者：
Carlo Visco
Alice Di Rocco
Andrea Evangelista
Francesca Maria Quaglia
Maria Chiara Tisi
Lucia Morello
Vittorio Ruggero Zilioli
Chiara Rusconi
Stefan Hohaus
Roberta Sciarra
Alessandro Re
Cristina Tecchio
Annalisa Chiappella
Ana Marin-Niebla
Rory McCulloch
Guido Gini
Tommasina Perrone
Luca Nassi
Elsa Pennese
Piero Maria Stefani
Maria Christina Cox
Valentina Bozzoli
Alberto Fabbri
Valentina Polli
Simone Ferrero
Maria Isabel Alvarez De Celis
Antonello Sica
Luca Petrucci
Luca Arcaini
Simon Rule
Mauro Krampera
Umberto Vitolo
Monica Balzarotti
机构：
[1] University of Verona,Department of Medicine, Section of Hematology
[2] Sapienza University,Department of Translational and Precision Medicine
[3] Azienda Ospedaliera Universitaria Città della Salute e della Scienza and CPO Piemonte,Unit of Clinical Epidemiology
[4] University of Verona,Department of Medicine, Section of Hematology
[5] San Bortolo Hospital,Cell Therapy and Hematology
[6] Humanitas Cancer Center,Humanitas Clinical and Research Center—IRCCS
[7] ASST Grande Ospedale Metropolitano Niguarda,Hematology
[8] IRCSS Istituto Nazionale Tumori,Hematology and Bone Marrow Transplantation
[9] Università Cattolica del Sacro Cuore,Hematology, Fondazione Policlinico Universitario A. Gemelli
[10] Fondazione IRCCS Policlinico San Matteo,Haematology
[11] Spedali Civili,Hematology
[12] “Città della Salute e della Scienza di Torino” University Hospital,Hematology
[13] Vall d’Hebron Institut of Oncology,Hematology
[14] University of Plymouth and Derriford Hospital,Haematology
[15] Department of Clinical and Molecular Sciences,Hematology
[16] Marche Polytechnic University,Hematology
[17] University of Bari,Hematology
[18] Azienda Ospedaliero-Universitaria Maggiore della Carità,Hematology
[19] UOSD “Centro Diagnosi e Terapia dei Linfomi”,Hematology
[20] PO Santo Spirito,Hematology
[21] General Hospital Ca’ Foncello,Hematology
[22] AOU Sant’Andrea,Hematology
[23] P.O. V. Fazzi,Hematology
[24] Azienda Ospedaliera Universitaria Senese & University of Siena,Hematology, Department of Molecular Biotechnologies and Health Sciences
[25] Ospedale degli Infermi,Hematology
[26] University of Torino/“Città della Salute e della Scienza di Torino” University Hospital,Hematology
[27] AUSLL/IRCCS Santa Maria Nuova Hospital,undefined
[28] Policlinico di Napoli,undefined
[29] Candiolo Cancer Institute,undefined
[30] FPO-IRCCS,undefined
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A Correction to this paper has been published: https://doi.org/10.1038/s41375-020-01119-8
引用
收藏
页码：932 / 932
相关论文
共 50 条
  • [21] Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
    Samad, Nousheen
    Younes, Anas
    ONCOTARGETS AND THERAPY, 2010, 3 : 167 - 178
  • [22] Novel therapies for relapsed/refractory mantle cell lymphoma
    Arora, Puja C.
    Portell, Craig A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 105 - 113
  • [23] Sequencing Therapies in Relapsed/Refractory Mantle Cell Lymphoma
    Portell, Craig A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S129 - S130
  • [24] Therapeutic options for relapsed/refractory mantle cell lymphoma
    Eyre, Toby A.
    Cheah, Chan Y.
    Wang, Michael L.
    BLOOD, 2022, 139 (05) : 666 - 677
  • [25] Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study
    Ansell, Stephen M.
    Tang, Hui
    Kurtin, Paul J.
    Koenig, Patricia A.
    Inwards, David J.
    Shah, Keith
    Ziesmer, Steven C.
    Feldman, Andrew L.
    Rao, Radha
    Gupta, Mamta
    Erlichman, Charles
    Witzig, Thomas E.
    LANCET ONCOLOGY, 2011, 12 (04): : 361 - 368
  • [26] TEMSIROLIMUS IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: DOES PROGNOSTIC RISK AFFECT OUTCOMES?
    Hess, G.
    Kang, L.
    Moran, P.
    HAEMATOLOGICA, 2012, 97 : 101 - 101
  • [27] Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
    Fisher, Richard I.
    Bernstein, Steven H.
    Kahl, Brad S.
    Djulbegovic, Benjamin
    Robertson, Michael J.
    de Vos, Sven
    Epner, Elliot
    Krishnan, Amrita
    Leonard, John P.
    Lonial, Sagar
    Stadtmauer, Edward A.
    O'Connor, Owen A.
    Shi, Hongliang
    Boral, Anthony L.
    Goy, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) : 4867 - 4874
  • [28] Treatment of Younger Patients With Mantle Cell Lymphoma
    Harel, Stephanie
    Delarue, Richard
    Ribrag, Vincent
    Dreyling, Martin
    Hermine, Olivier
    SEMINARS IN HEMATOLOGY, 2011, 48 (03) : 194 - 207
  • [29] Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
    Baggio, Diva
    Wellard, Cameron
    Chung, Eliza
    Talaulikar, Dipti
    Keane, Colm
    Opat, Stephen
    Giri, Pratyush
    Minson, Adrian
    Cheah, Chan Yoon
    Armytage, Tasman
    Lee, Denise
    Chong, Geoffrey
    Johnston, Anna
    Cochrane, Tara
    Waters, Neil
    Hamad, Nada
    Wood, Erica M.
    Hawkes, Eliza A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 621 - 627
  • [30] Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma
    Mussetti, Alberto
    Kumar, Anita
    Dahi, Parastoo B.
    Perales, Miguel-Angel
    Sauter, Craig S.
    BLOOD REVIEWS, 2015, 29 (03) : 143 - 152
12345